Implant Sciences Corp. (OTCPK:IMSC) is looking to expand the markets where its Quantum Sniffer explosive and narcotics detectors are deployed, as the company continues to pursue and win key contracts.
Founded in 1984, Implant Sciences
Corp. develops and commercializes explosives and narcotics trace
detection solutions for transportation and aviation security, force
protection, law enforcement, critical infrastructure protection, and
public safety markets.
The company successfully introduced its
first handheld explosive trace detection product in 2003 and has sold
over 1,500 systems to more than 30 countries around the world,
generating over $25 million in revenues. Homeland Security Research
Corporation estimates that the global explosives trace detection market
including equipment, services, and supplies will to grow to
approximately $1 billion by 2015.
Speaking to Proactive Investors, Implant Sciences'
VP of Technology, Todd Silvestri said: "We are seeing numerous markets
around the world that can be pursued given the capabilities of the
equipment." Indeed, Implant Sciences'
Quantum Sniffer devices were recently deployed in Colombia at the
Summit of the Americas, where they were used by security staff at the
venue's cargo, press and main entrances.
Leveraging its patented technology, Implant Sciences’ Quantum Sniffer QS-H150 handheld explosives trace detector is in use throughout the world. Implant Sciences
also manufactures and sells the Quantum Sniffer QS-B220 bench-top
which, with its small footprint, is well-suited for crowded security
checkpoints, whether for passengers, baggage, or air cargo.
products employ Ion Mobility Spectrometry technology to detect trace
explosives, incorporating the company's patented non-radioactive
ionization technology and fully automatic self-calibration. Devices
containing radioactive materials are subject to many regulations that
require licensing, testing, shipping, and specialized disposal. Implant Sciences'
Todd Silvestri said that in his experience, when confronted with a
choice of detection devices with radioactive or non-radioactive
components, "...many clients prefer the non-radioactive solution".
sniffers are currently in use in locations as diverse as airports and
subways in China, ports in California, ferry ships in Massachusetts, and
at Turkey's Istanbul Stock Exchange. In March, Implant Sciences
also announced that it shipped additional units of its QS-H150 portable
explosives detector to be deployed in the U.K., Taiwan and India.
But these are not the only places where Implant Sciences' equipment is deployed.
Brad Chase, Implant Sciences'
Marketing Director said: "We see increased use of our equipment by
corporations, for example, to secure headquarter facilities. Other
business users include banks, hotels, and manufacturing plants. They all
have identified a need to detect explosives entering their facilities."
is currently seeking certification from the Department of Homeland
Security's Transportation Security Administration to add the QS-B220 to
the Air Cargo Screening Technology List. This certification would allow
the B220 Quantum Sniffer to be used in meeting the mandate to screen
100% of air cargo bound for U.S. airports.
Governments around the world are experiencing a wave of austerity spending measures; however Implant Sciences
is confident that sales will continue. Brad Chase commented "The
problem of terrorism isn’t going away. We don’t see orders getting
cancelled, just postponed or deferred."
But Implant Sciences isn't limiting itself to what it can do today.
continue to focus on increasing the number of threats we can detect and
improving our systems sensitivities to those threats. We added
narcotics detection with the QS-B220, which opens many new markets for
us. We strive to continuously improve our capabilities to stay ahead of
the potential threats which may be perpetrated," Implant Sciences' Todd Silvestri said.